Prime
Treatments
Testing and Advancements Index
The Prime Treatments, Testing and Advancements Index is designed to track both event-driven news and long-term trends of companies engaged in developing treatments and vaccines, or diagnostic technology, in the fight against infectious diseases.
FACT SHEET
Prime Treatments, Testing and Advancements Primer
PDF
Infectious Diseases: Prime Treatments, Testing and Advancements Overview
PDF
Prime Treatments, Testing and Advancements Index Methodology Guide
PDF
Prime Treatments, Testing and Advancements Factsheet
PDF
Prime Treatments, Testing and Advancements Index
VIDEO
INDEX KEY FACTS
Base Date: December 12, 2019
Total number of holdings:
54
Launch date: June 08, 2020
Reconstitution: Quarterly (March, June, September and December)
Index calculation agent: Solactive AG
Weighting scheme: Modified Market Capitalization
INDEX SYMBOLS
| Version | Bloomberg | Reuters | ISIN |
|---|---|---|---|
| Prime Treatments, Testing and Advancements Index GTR | PGERM | .PGERMG | DE000SL0A030 |
| Prime Treatments, Testing and Advancements Index NTR | N/A | .PGERMN | DE000SL0A022 |
| Prime Treatments, Testing and Advancements Index PR | N/A | .PGERMP | DE000SL0A014 |
INDEX COMPOSITION
| Component Name | Ticker | Weight |
|---|---|---|
| MODERNA INC | MRNA | 7.69% |
| QUEST DIAGNOSTICS INC | DGX | 7.24% |
| BIONTECH SE | BNTX | 6.51% |
| ALNYLAM PHARMACEUTICALS INC | ALNY | 6.35% |
| LABORATORY CRP OF AMER HLDGS | LH | 6.14% |
| IMMUNITYBIO INC | IBRX | 4.81% |
| QUIDELORTHO CORPORATION | QDEL | 3.88% |
| IMMUNOCORE HOLDINGS PLC | IMCR | 3.84% |
| DYNAVAX TECHNOLOGIES CORP | DVAX | 3.82% |
| BIO-RAD LABORATORIES INC | BIO | 3.77% |
| VAXCYTE INC | PCVX | 3.62% |
| ZAI LAB LTD | ZLAB | 3.34% |
| VIR BIOTECHNOLOGY INC | VIR | 2.70% |
| OPKO HEALTH INC | OPK | 2.47% |
| BIOCRYST PHARMACEUTICALS INC | BCRX | 2.25% |
| ARCTURUS THERAPEUTICS HOLDINGS INC | ARCT | 1.83% |
| SIGA TECHNOLOGIES INC | SIGA | 1.61% |
| FULGENT GENETICS INC | FLGT | 1.55% |
| HILLEVAX INC | HLVX | 1.52% |
| NOVAVAX INC | NVAX | 1.45% |
| CUREVAC BV | CVAC | 1.35% |
| ARBUTUS BIOPHARMA CORP | ABUS | 1.19% |
| ASTRAZENECA PLC-SPONS ADR | AZN | 1.08% |
| ORASURE TECHNOLOGIES INC | OSUR | 1.01% |
| ALTIMMUNE INC | ALT | 1.01% |
| ADAPTIVE BIOTECHNOLOGIES CORP | ADPT | 0.99% |
| SANOFI-ADR | SNY | 0.96% |
| MERCK & CO. INC. | MRK | 0.95% |
| GSK PLC-SPON ADR | GSK | 0.91% |
| ELI LILLY & CO | LLY | 0.89% |
| PFIZER INC | PFE | 0.88% |
| ABBVIE INC | ABBV | 0.88% |
| REGENERON PHARMACEUTICALS | REGN | 0.86% |
| JOHNSON & JOHNSON | JNJ | 0.84% |
| GILEAD SCIENCES INC | GILD | 0.84% |
| ABBOTT LABORATORIES | ABT | 0.84% |
| TAKEDA PHARM-ADR | TAK | 0.83% |
| ATEA PHARMACEUTICALS INC | AVIR | 0.81% |
| OCUGEN INC | OCGN | 0.79% |
| CORMEDIX INC | CRMD | 0.74% |
| ENANTA PHARMACEUTICALS INC | ENTA | 0.69% |
| XBIOTECH INC | XBIT | 0.65% |
| RENOVARO BIOSCIENCES INC | RENB | 0.64% |
| INVIVYD INC | IVVD | 0.60% |
| INOVIO PHARMACEUTICALS INC | INO | 0.60% |
| VAXART INC | VXRT | 0.29% |
| EMERGENT BIOSOLUTIONS INC | EBS | 0.26% |
| INFLARX NV | IFRX | 0.21% |
| CHIMERIX INC | CMRX | 0.21% |
| CEL-SCI CORP | CVM | 0.20% |
| GRITSTONE BIO INC | GRTS | 0.19% |
| AN2 THERAPEUTICS INC | ANTX | 0.18% |
| CUE BIOPHARMA INC | CUE | 0.17% |
| VAXXINITY INC | VAXX | 0.04% |